ARCHIVES

FDA Proposes Office For Patients With Life Threatening Disease

This article is from The Cancer Letter archive.

Vol. 18 No. 44 | November 13, 1992

Download PDF Visit The Full Archive

Related Articles

Gene Therapy Experiments Get RDAC Okay

August 10, 1990

Funding Opportunity: Stand Up To Cancer Canada to Fund Two Dream Teams

October 17, 2014

How ImClone’s “Hot” New Drug Got Cold Shoulder From FDA

March 8, 2002

FDA Committee Oks AMSA for Group C List, Tables THC Request, Deadlocks On Estramustine NDA

July 3, 1981

DCT Issues New Program Announcement On Clinical Research

December 5, 1980

FDA Advisors Uphold Broad Mandate To Limit Use Of ESA Products In Cancer Indications.

May 11, 2007